# Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets

> **NCT03979417** · — · COMPLETED · sponsor: **Institut Pasteur** · enrollment: 14 (actual)

## Conditions studied

- Hepatopathy
- Fibrosis

## Interventions

- **OTHER:** Blood draw and liver resection

## Key facts

- **NCT ID:** NCT03979417
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-30
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-26
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979417, "Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03979417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*